388654 DNA Modification of Collagen Scaffolds for Applications in Regenerative Medicine

Wednesday, November 19, 2014: 12:46 PM
International 7 (Marriott Marquis Atlanta)
Millicent O. Sullivan, Chemical and Biomolecular Engineering, University of Delaware, Newark, DE, Morgan A. Urello, Chemical & Biomolecular Engineering, University of Delaware, Newark, DE and Kristi L. Kiick, Materials Science and Engineering, University of Delaware, Newark, DE

The use of collagen-based biomaterials in regenerative medicine has rapidly increased over the past decade due to the biocompatibility, approved clinical usage, and broad importance of collagens in mammalian tissues.  During this period, a variety of collagen modification techniques have been developed for the purpose of retaining and delivering therapeutics.  Many techniques rely on chemical treatments, but a biomimetic strategy to modify collagen scaffolds offers compelling advantages.  We have designed a collagen mimetic peptide (CMP)-based approach to create DNA-linked collagens for applications in therapeutic gene transfer.  CMPs offer an enormously versatile (and reversible) method for modification of collagen with a range of materials.  We created CMPs with a range of hybridization temperatures (Tm) on collagen I, and demonstrated the functionalization of DNA polyplexes with addressable CMPs at a range of densities.  The retention of DNA polyplexes on collagen could be directly manipulated through variation of the CMP density on the polyplexes, and the CMP-based retention strategy also increased polyplex stability and sustained gene transfer over a period of several weeks in cultured murine fibroblasts.  This novel collagen modification approach offers new opportunities to address key issues in therapeutic gene transfer for applications in regenerative medicine.

Extended Abstract: File Not Uploaded
See more of this Session: Biomaterials for Drug and Gene Delivery
See more of this Group/Topical: Materials Engineering and Sciences Division